• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    7.74 Down 0.57(6.86%) Apr 29, 4:00PM EDT
    Prev Close:8.31
    Open:8.33
    Bid:7.74 x 700
    Ask:7.85 x 2500
    1y Target Est:24.17
    Beta:0.890347
    Next Earnings Date:N/A
    Day's Range:7.63 - 8.33
    52wk Range:5.21 - 30.13
    Volume:716,504
    Avg Vol (3m):926,260
    Market Cap:263.94M
    P/E (ttm):N/A
    EPS (ttm):-1.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSDown 6.86%263.94M
    VICLUp 1.01%36.71M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-16) :-1.94
    Quarterly EPS Est (Apr-16) :-0.50
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback